Cite
HARVARD Citation
Bochtler, T. et al. (2020). Integrated clinicomolecular characterization identifies RAS activation and CDKN2A deletion as independent adverse prognostic factors in cancer of unknown primary. International journal of cancer. 146 (11), pp. 3053-3064. [Online].